The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Press Commentary

28 Oct 2022 07:00

RNS Number : 4301E
Bidstack Group PLC
28 October 2022
 

28 October 2022

Bidstack Group Plc

("Bidstack" or the "Company" or the "Group")

Update re Press Commentary

Further to the Company's strategy update to the market on 26 October 2022, the Board notes recent press commentary regarding a private communication by the Company with certain investors concerning an email received from Azerion, which the Directors have been advised did not require disclosure under either the AIM Rules or MAR. In order to ensure that all shareholders have parity of information the Company wishes to give this update.

After the announcement on 5 October 2022 of the Group's Fundraise, Bidstack received an email from Azerion requesting certain information and reserving its rights under the Azerion agreement.

Given the nature of the Group's strong ongoing commercial relationship with Azerion and the extensive work taking place on the ground to ensure the success of the partnership by both Azerion and Bidstack, the Directors were surprised to receive this email.  At a commercial level, the Group's arrangements with Azerion continue to be operated on a 'business as usual' basis by both parties, with October already the highest grossing month to date and with November and December anticipated to grow further month on month. Bidstack has responded with detailed information demonstrating the Group's compliance with all areas identified. Bidstack has taken appropriate external legal advice and has concluded that Azerion has no present entitlement to end its agreement with the Group.

As referred to in the Company's announcement on 26 October 2022, following early evidence of its success in selling directly into North America and Japan, Bidstack intends to undertake a comprehensive business review, specifically reassessing and renegotiating, where appropriate, both existing and new reseller engagements in all geographies in order to maximise the benefits of its contacts with developers, publishers, ad-tech vendors and media companies.

Bidstack notes that Azerion is primarily a European-based group, with its sales-reach strongest in these territories. As announced on 20 September and 13 and 26 October, Bidstack has now invested in an experienced sales team with a proven track record in North America, which has a robust pipeline for FY23.

Bidstack's newly appointed Group Chief Revenue Officer is in active discussions on a number of significant global revenue opportunities, including additional resellers, licensors and media agreements, with anticipated contracts in FY23.

The Company would like to stress that, contrary to the press commentary, there is no litigation with Azerion, and the contract with Azerion continues to operate as expected.

The Directors also confirm that there are no discussions with Azerion regarding any offer for the Company.

The Board believes that the Company is trading in line with market expectations for the years ended 31 December 2022 and 2023.

-ENDS-

Contacts

Bidstack Group Plc

James Draper, CEO

 

via Buchanan

SPARK Advisory Partners Limited (Nomad)

Mark Brady / Neil Baldwin / James Keeshan

 

+44 (0) 203 368 3550

Stifel Nicolaus Europe Limited (Broker)

Fred Walsh / Tom Marsh

 

+44 (0) 20 7710 7600

Buchanan Communications Limited

Chris Lane / Stephanie Whitmore / Kim van Beeck

bidstack@buchanan.uk.com

 

+44 (0) 20 7466 5000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFIFEIILLTFIF
Date   Source Headline
17th Aug 200711:30 amRNSAIM Rule 26
19th Jul 20079:00 amRNSBUPA completes investment
11th Jul 20079:22 amRNSApplication for Listing
3rd Jul 200710:45 amRNSApplication for Listing
22nd Jun 20077:01 amRNSBUPA take 29.9% stake
11th Jun 20077:00 amRNSAgreement with Alliance Boots
5th Jun 20077:01 amRNSAgreement with Esporta
29th May 20071:03 pmRNSResult of EGM
4th May 20072:53 pmRNSNotice of EGM
25th Apr 20077:00 amRNSInterim Results
13th Apr 200712:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20078:42 amRNSTotal Voting Rights
19th Jan 20072:37 pmRNSPlacing
15th Dec 20062:45 pmRNSTotal Voting Rights
14th Dec 20066:02 pmRNSResult of AGM
14th Nov 20067:02 amRNSFinal Results
26th Jul 20068:08 amRNSAcquisition
5th Jun 20067:00 amRNSAgreement with PruHealth
5th May 20069:30 amRNSContract Win
12th Apr 20064:37 pmRNSOptions Granted
10th Apr 200610:34 amRNSInterim Results
27th Feb 20067:00 amRNSDisposal of Liberation
9th Feb 20067:00 amRNSContract with Leisure Op.
16th Dec 20052:27 pmRNSAGM Statement
23rd Nov 20057:01 amRNSUS Licensing Agreement
16th Nov 20057:02 amRNSFinal Results
25th Aug 20054:42 pmRNSDirector/PDMR Shareholding
4th Aug 200512:22 pmRNSShare Price/Press Speculation
25th Jul 20057:00 amRNSDirectors Holding / Update
5th May 20054:56 pmRNSResult of EGM
18th Apr 20057:00 amRNSInterim Results
13th Apr 20057:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.